COPD exacerbations in the phase 3 revefenacin clinical trial program

J. Donohue (Chapel Hill, NC, United States of America), S. Sethi (Buffalo, NY, United States of America), C. Barnes (South San Franscico, CA, United States of America), E. Moran (South San Franscico, CA, United States of America), S. Pendyala (South San Franscico, CA, United States of America), G. Crater (South San Franscico, CA, United States of America), B. Haumann (London, UK, United Kingdom)

Source: International Congress 2018 – Clinical trials in COPD: new results
Session: Clinical trials in COPD: new results
Session type: Oral Presentation
Number: 1655
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Donohue (Chapel Hill, NC, United States of America), S. Sethi (Buffalo, NY, United States of America), C. Barnes (South San Franscico, CA, United States of America), E. Moran (South San Franscico, CA, United States of America), S. Pendyala (South San Franscico, CA, United States of America), G. Crater (South San Franscico, CA, United States of America), B. Haumann (London, UK, United Kingdom). COPD exacerbations in the phase 3 revefenacin clinical trial program. 1655

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations
Source: ERJ Open Res, 5 (4) 00136-2019; 10.1183/23120541.00136-2019
Year: 2019



A randomised clinical trial to assess the effect of active muscle stimulation on hospitalised patients with COPD exacerbations
Source: Annual Congress 2012 - The best posters on physical inactivity, muscle dysfunction and exercise intolerance
Year: 2012

A randomised controlled trial of individualised, progressed early exercise in patients hospitalised with an acute exacerbation of chronic obstructive pulmonary disease (AECOPD)
Source: International Congress 2015 – Latest insights in pulmonary rehabilitation and functional capacity
Year: 2015


Early pulmonary rehabilitation after acute exacerbation of COPD: a randomised controlled trial
Source: ERJ Open Res, 6 (1) 00173-2019; 10.1183/23120541.00173-2019
Year: 2020



Comprehensive care programme for patients with chronic obstructive pulmonary disease (COPD) --- A randomized controlled trial (RCT)
Source: International Congress 2015 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2015

Short-term telemonitoring program after hospital discharge for COPD exacerbation: Greek pilot of the renewing health multicenter randomized trial
Source: International Congress 2015 – Tele-rehabilitation in chronic lung diseases
Year: 2015



Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial
Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Year: 2013

Time-to-treatment failure in the Belgian randomized controlled trial with azithromycin for acute COPD exacerbations requiring hospitalization
Source: International Congress 2016 – Highlights in the management of COPD and beyond
Year: 2016


A multi-centre, randomised controlled trial of positive expiratory pressure mask therapy for inpatients with acute exacerbations of COPD and sputum expectoration
Source: Annual Congress 2013 –Rehabilitation, exercise and adjunct physiotherapy techniques in different respiratory conditions
Year: 2013



The utility of tiotropium among patients with chronic obstructive pulmonary disease (COPD): An updated meta-analysis of randomized controlled trials
Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care
Year: 2013


Late Breaking Abstract - First-time assessment of efficacy of candidate vaccine to prevent acute exacerbations of chronic obstructive pulmonary disease (AECOPD): multicentre, randomised, controlled, observer-blind phase 2b trial
Source: Virtual Congress 2021 – ALERT: COPD
Year: 2021



Clinical characteristics of patients with frequent COPD exacerbations in a Swiss multicenter COPD cohort study (TOPDOCS)
Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care
Year: 2016


Validation of the recording of acute exacerbations of COPD in the clinical practice research datalink: Phase 1 results
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015

ß-blockers in exacerbations of COPD: feasibility of a randomised controlled trial
Source: ERJ Open Res, 3 (1) 00090-2016; 10.1183/23120541.00090-2016
Year: 2017



Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015


Procalcitonin-guided antibiotic therapy in acute exacerbations of COPD (AECOPD): a randomised trial - The ProCOLD Study
Source: Eur Respir J 2005; 26: Suppl. 49, 464s
Year: 2005

Analysis of the frequency of COPD exacerbations in the ’real-life’ DACCORD study over a 2 year period
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016


A global survey conducted to determine frequency of exacerbations in COPD patients
Source: Annual Congress 2013 –COPD treatment
Year: 2013


Telehealthcare in COPD – A feasibility trial
Source: International Congress 2016 – Non-inflammatory assessment of airway disorders
Year: 2016